India s daily average Covid vaccinations dipped by nearly 50% between April and May theprint.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theprint.in Daily Mail and Mail on Sunday newspapers.
Text Size:
A+
New Delhi: If you are in the 18-44 years age group and have spent an inordinate amount of time tracking the CoWin platform to book a vaccination slot in what feels like a morbid game of ‘fastest finger first’, you have another 58.89 crore Indians for company.
The reason: There are not enough vaccines ready to carry out the vaccination programme at the earlier pace. Thus, state governments and private hospitals have been struggling to vaccinate not just young people but even those that had become eligible earlier.
On Friday, in what may be the first admission from the Government of India that vaccine doses are indeed not plentiful, the health ministry said states had been asked to prioritise administering the second dose and use supplies from the Centre in a 70:30 ratio of second and first doses.
Text Size:
A+
New Delhi: India has turned down the US proposal to send a Covid-19 ‘Strike Team’, which would have constituted members of the Epidemic Intelligence Service apart from others, saying New Delhi had never sought one. India said all and any such collaboration will be undertaken through a virtual medium, ThePrint has learnt.
“There is no so-called American ‘strike team‘ in India or on its way. India is fine with technical personnel who are coming in for assistance of certain equipment being sent in from abroad as they have different operating systems and are not a pure plug-and-play technology. It needs to be made compatible to the India system and the Indian operators need to be trained,” a source in the central government told ThePrint.
Pfizer vaccine prevents symptomatic & asymptomatic Covid infections in adults, UK study shows
A single dose of the vaccine has shown a 70% effectiveness 21 days after the dose and 85% effectiveness 7 days after two doses.
Samyak Pandey 24 April, 2021 6:18 pm IST Text Size:
A+
New Delhi: Pfizer-BioNTech’s Covid-19 vaccine can prevent both symptomatic and asymptomatic infection in working-age adults, a new study claims.
Officially called the BNT162b2 vaccine, the inoculation was studied among a sample population when the B1.1.7 variant of the coronavirus was dominantly circulating in the UK.
The Lancet, was conducted by Public Health England, which comes under the UK’s Department of Health and Social Care, and the National Institute for Health Research.